Abstract
Among many kinds of somatic stem cells, hematopoietic stem cells are the cells that have been successfully applied to treating leukemia patients as forms of bone marrow and cord blood transplantation. Mesenchymal stem cells, collectable from several sources including the bone marrow and adipose tissue, are also widely applied to clinical trials for their easy accessibility and low risks of tumorigenesis, while their outcomes were shown to be not clinically relevant in several target diseases. The most important issue for the stem cells is whether the cells are safe and effective for curing diseases. In this chapter, the outline of the clinical trial in Muse cells is discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Japan KK, part of Springer Nature
About this chapter
Cite this chapter
Dezawa, M. (2018). Clinical Trials of Muse Cells. In: Dezawa, M. (eds) Muse Cells. Advances in Experimental Medicine and Biology, vol 1103. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56847-6_17
Download citation
DOI: https://doi.org/10.1007/978-4-431-56847-6_17
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56845-2
Online ISBN: 978-4-431-56847-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)